Source: Taiwantrade | Updated: 11 September 2012
K.S. Clifford Chao, chairman of the Combined Program in Radiation Oncology at New York's Presbyterian Hospital, said the therapy system can map the exact location of a tumor and accurately direct radiation toward malignant cells without damaging surrounding healthy tissue.
After five years of painstaking development, Arc-Knife's breakthrough technology is now mature enough for mass production, Chao said.
The technology has already drawn interest from foreign investors, but Chao said he wishes to bring the system to Taiwan to contribute to the country's biotechnology sector.
Chao, who has nearly 30 years of experience in oncology care, received his medical degree from Kaohsiung Medical School in Taiwan.
He is also a director and professor at the prestigious Weill Cornell Medical College and Columbia University Medical Center.